EMR PEG Ratio Analysis

The PEG ratio, which measures a stock’s price-to-earnings multiple relative to its expected earnings growth, stands at 1.37x for EMR — a level that suggests the market is paying more than one times growth, implying moderate valuation.

Compared to sector peers, EMR trades above the sector median of 0.81x and sits at the 63rd percentile, meaning it is pricier than most of its industry. The year-over-year change is not available, and the last 8 quarters of history are also not available; however, the quarter-over-quarter change shows a +15.1% increase from the prior reading of 1.19x. A rising PEG ratio alongside a level already above the sector median points to a less attractive valuation relative to growth, which could limit upside if earnings expectations do not catch up. This trend introduces a mild valuation headwind, but the single available comparison limits how strongly this can be interpreted. Overall, this metric leans toward overvaluation and therefore tilts against a bullish case, yet it does not decisively contradict the NEUTRAL verdict — it supports caution rather than a clear buy or sell signal.

Frequently Asked Questions